1 Min Read
Feb 9 (Reuters) - Ajanta Pharma Ltd:
* SAYS FORMULATION FACILITY AT DAHEJ WAS INSPECTED BY US FDA FROM 5TH TO 9TH FEBRUARY
* SAYS NO FORM 483 WAS ISSUED TO CO Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.